Johnson & Johnson MedTech
J&J MedTech surgical robotics division developing the OTTAVA robotic surgical system and VELYS orthopedic robot.
Johnson & Johnson MedTech is the medical technology segment of Johnson & Johnson, headquartered in New Brunswick, New Jersey. The division develops surgical robotics platforms including the OTTAVA robotic surgical system for soft-tissue general surgery, the VELYS robotic-assisted solution for orthopedic procedures, and the Monarch endoscopy platform. OTTAVA, submitted to the FDA for De Novo clearance in January 2026, is designed for minimally invasive upper abdominal procedures and completed its first clinical cases in 2025.
J&J MedTech integrates robotics, digital surgery, and advanced energy devices to offer a comprehensive ecosystem across multiple surgical specialties on a global scale.
Primary type & automation activities this supplier delivers:
OTTAVA Robotic Surgical System
J&J MedTech soft-tissue robotic surgical platform for general and abdominal surgery.
Contact Johnson & Johnson MedTech
WEBSITE
https://jnj.comPHONE
+1 (732) 524-0400HEADQUARTERS
United States
Company Facts
Founded
1886
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-
Ophthalmic Surgical Robot Achieves Micron-Level Precision in Three Minutes
An innovative ophthalmic surgical robot has demonstrated the ability to restore vision in nearly blind patients within just three minutes, achieving precision at the micron level. This advancement in robotic surgery signifies a major leap forward in ophthalmology, potentially transforming treatment options for patients with severe vision impairment. The significance of this technology lies in its ability to perform complex surgical procedures with unprecedented accuracy, which could lead to improved outcomes for patients suffering from various eye conditions. The robot's rapid operation time and high precision could also reduce the overall burden on healthcare systems by streamlining surgical processes. Looking ahead, the continued development and deployment of this ophthalmic surgical robot will be crucial. Stakeholders in the healthcare and robotics sectors should monitor advancements in this technology, as it may pave the way for further innovations in minimally invasive surgical techniques. No further timeline was disclosed at the time of publication.
Robotics Automation AI
IndexBox Forecasts 16.8% Growth in AI Surgical Robot Market by 2035 Amid Surgeon Shortage
According to the latest report by IndexBox, the global AI surgical robot market is entering a structural expansion phase, with demand expected to accelerate before 2035. The market is diversifying into high-end efficiency-driven segments and emerging value-oriented segments, influenced by surgeon shortages and the rising need for minimally invasive surgeries. The significance of this growth lies in the shift from pure institutional procurement to a hybrid model, where preferences of end-surgeons and patient awareness increasingly impact capital equipment purchases. Key demand drivers include advancements in AI and robotics, increased healthcare spending, and the expansion of robotic surgeries into new clinical applications beyond urology and gynecology. Looking ahead, the market is projected to experience a compound annual growth rate of 12.0% from 2026 to 2035, with North America maintaining the largest market share at 40%. No further timeline was disclosed at the time of publication.
AI Surgical Robots Healthcare Technology Robotics Minimally Invasive Surgery Market Trends
CITIC Securities Identifies Turning Point in Medical Device Sector with Focus on Brain-Computer Interfaces and AI Healthcare
CITIC Securities has reported that the medical device sector is reaching a turning point, with opportunities for performance and valuation recovery expected by 2026. The report emphasizes the importance of focusing on companies that are improving their performance and exploring international markets, particularly those listed in Hong Kong. The long-term outlook for the medical device sector is driven by innovation, international expansion, and mergers and acquisitions. The report highlights that the sector's innovative capabilities are gaining recognition, leading to a reconstruction of valuations. Short-term opportunities include capitalizing on performance recovery in high-value consumables and IVD segments, with several leading companies poised for accelerated growth by 2026. Investors are advised to keep an eye on emerging technologies such as surgical robots and brain-computer interfaces, as breakthroughs in these areas are expected to catalyze interest in the sector. The report also notes potential risks, including policy changes, research and development setbacks, and geopolitical uncertainties in the Middle East.
Medical Devices AI Healthcare Brain-Computer Interfaces Surgical Robots Innovation
Newport Hospital Becomes First in Rhode Island to Install Da Vinci Surgical Robot Funded by Donations
Newport Hospital has become the first facility in Rhode Island to install the Da Vinci Surgical Robot, specifically the Da Vinci 5 model. This advanced robotic-assisted surgical platform, funded entirely by donations after a year of fundraising, will be utilized for minimally invasive surgeries in urology, gynecology, thoracic, and general surgery. The significance of this installation lies in its enhancement of surgical precision and capabilities within a community hospital setting. According to Tenny Thomas, President and Chief Medical Officer of Newport Hospital, this milestone was made possible through the generous support of the donor community. The Da Vinci 5 offers improved force feedback, imaging, and computing power compared to its predecessors, reinforcing the hospital's commitment to providing advanced surgical options. Looking ahead, the integration of the Da Vinci 5 into Newport Hospital's surgical offerings, alongside the Zimmer Biomet ROSA knee system, highlights the ongoing relevance of specialized surgical robots in clinical practice. While humanoid robots like the Yushu G1 are still in early feasibility studies, the successful deployment of the Da Vinci 5 underscores its position as a leading solution in modern surgical procedures.
Surgical Robotics Minimally Invasive Surgery Healthcare Technology Robotic Surgery
Samsung Medical Center Performs First Surgery with Humanoid Robots Assisting Surgeons
On September 16, Samsung Medical Center in Seoul conducted a simulated surgery with two humanoid robots assisting a surgical team. The robots, dressed in surgical attire, successfully collaborated with the lead surgeon, Professor Woo Nam-ki, by retrieving and delivering surgical instruments upon request. This marks a significant advancement in robotic assistance in surgery, showcasing the potential for robots to work alongside human medical professionals. The importance of this development lies in its potential to address staffing challenges in hospitals, particularly in smaller facilities where skilled surgical assistants may be scarce. Professor Jung Yong-ki emphasized that if a robot can effectively replace a human assistant, it could lead to cost-effective solutions for maintaining surgical operations around the clock. The robots demonstrated a 100% success rate in grasping surgical instruments and a 98.7% success rate in instrument delivery, highlighting their reliability in the operating room. Looking ahead, the project is set to progress with plans for commercialization led by Rainbow Robotics and AIDIN ROBOTICS. The first clinical trials are expected to begin in 2029, starting with low-risk endoscopic tasks before expanding to more complex procedures. The ongoing development of AI capabilities, including tactile feedback and predictive analytics, will further enhance the robots' performance in surgical environments.
Humanoid Robots Surgical Robotics AI in Healthcare Medical Technology
Innovation Works Venture Expo 2026: 58 Pittsburgh Startups Pitch to Investors
58 health, deep tech and robotics startups pitched at Innovation Works Venture Expo 2026 in Pittsburgh. Full company list, program and 2025 funding data.
Professor Meng Qinghu Recognized as Fellow of the Royal Society of Canada for 2026
Professor Meng Qinghu, head of the Department of Electronic and Electrical Engineering at Southern University of Science and Technology and chief scientist at Yuanhua Intelligent Technology, has been elected as a Fellow of the Royal Society of Canada (RSC) for 2026. He is the only scholar from a mainland Chinese university among the 105 new fellows announced. This recognition highlights Professor Meng's significant contributions to the fields of robotics and intelligent systems, particularly in medical robotics, where he is regarded as a pioneering researcher. His work includes advancements in control algorithms, robotic prosthetics, and orthopedic surgical robots, which have been successfully applied in over 5,000 surgeries, providing substantial clinical value. Looking ahead, Professor Meng's election underscores the growing international recognition of his research and the capabilities of Yuanhua Intelligent Technology in advancing medical robotics technology. No further timeline was disclosed at the time of publication.
Medical Robotics Intelligent Systems Robotics Research AI
Humanoid Robot Successfully Performs Gallbladder Surgery on Live Pigs, According to Nature Study
A research team from the University of California, San Diego, utilized the humanoid robot developed by Yushu Technology to perform gallbladder surgeries on live pigs, marking a significant milestone in robotic surgery. This is the first instance of a humanoid robot conducting live surgeries, showcasing its potential in clinical settings. The significance of this research lies in its exploration of humanoid robots in surgical environments, which have traditionally relied on specialized robotic systems like the da Vinci Surgical System. The study highlights the humanoid robot's ability to operate in existing surgical environments without requiring extensive modifications, potentially reducing costs and increasing accessibility. Looking ahead, while the humanoid robot demonstrated notable advancements, it still faces challenges in precision compared to specialized surgical robots. The study indicates that further developments are needed before humanoid robots can be considered for clinical use. No further timeline was disclosed at the time of publication.
Humanoid Robots Surgical Robotics Medical Technology Robotic Surgery
Advancements in Surgical Robots and Real-World Warehouse Automation Explored
The September 2026 digital issue of The Robot Report highlights significant advancements in surgical robotics and warehouse automation. It features case studies from El Camino Health, where the da Vinci system from Intuitive Surgical is utilized for coronary artery bypass grafting, emphasizing the need for precise motion control to enhance patient outcomes and reduce complications. This report is crucial for commercial robotics developers and end users as it illustrates the successful integration of robotic systems in healthcare and logistics. El Camino Health's implementation of robotic surgery not only alleviates cognitive burdens on staff but also improves care consistency and accessibility, showcasing the potential of surgical robots in modern medicine. Additionally, the report discusses the integration of autonomous mobile robots (AMRs) in warehouse operations, highlighting their independent capabilities compared to traditional automated guided vehicles. As AMRs become more prevalent in third-party logistics, retailers, and manufacturing, best practices for their deployment and maintenance will be essential for maximizing efficiency and investment returns. No further timeline was disclosed at the time of publication.
Autonomous Mobile Robots (AMRs) Case Study Controllers Digital Issues Healthcare Robotics Logistics
New Insights on Domestic Orthopedic Surgical Robots: Advancements in Complex Joint Replacement
The maturity of surgical robots is evaluated not just by their ability to perform standard joint replacements but also by their effectiveness in complex cases. At the 12th Asian Joint Society Annual Meeting held from September 10 to 12, 2023, in Boao, Hainan, experts discussed the challenges of robotic-assisted surgeries for patients with significant anatomical deviations. The event showcased the Kuntuo® orthopedic surgical robot in various scenarios, including live surgeries and workshops, emphasizing its role in addressing complex cases. A notable case involved a 66-year-old woman with developmental dysplasia of the hip, highlighting the need for personalized planning in joint replacement surgeries. The robot's capabilities extend beyond precision to include individualized preoperative planning based on patient-specific anatomical conditions. Future developments in robotic-assisted surgeries will likely focus on enhancing the robot's ability to adapt to unique anatomical challenges. The Kuntuo robot has previously been utilized in complex cases, indicating its growing relevance in orthopedic surgery. No further timeline was disclosed at the time of publication.
Orthopedic Robotics Surgical Automation Complex Case Management Medical Technology
RobotToday Weekly Briefing August 31 – September 4, 2026
This week in robotics: NVIDIA agrees to buy Hugging Face for $12.93 billion, Figure signs a $3.5 billion compute deal with Nscale for up to 100,000 GPUs, Tesla launches steering-wheel-free Cybercabs in Austin under NHTSA scrutiny, and Uber and Wayve bring the UK its first autonomous rides. August 31 – September 4, 2026.
Robotics Investing: Intuitive Surgical or Unitree?
Unitree (STAR 688836) trades near 410x earnings after a 46% drawdown; Intuitive Surgical sits at 42.5x. A definition-aligned comparison of both companies.
ROBOTTODAY WEEKLY BRIEFING August 24 – 28, 2026
This week in robotics: XPeng's Dogotix raises over $900 million at a $6.3 billion valuation, Unitree's post-IPO slump revives bubble talk, Beijing's World Humanoid Robot Games close with a shift to real-world tasks, and Teradyne sues JAKA at Europe's Unified Patent Court. August 24–28, 2026.
WRC 2026 Robot Systems: 149 Companies That Build Robots
149 of the 248 classified WRC 2026 exhibitors build finished robots. 93 build humanoid or legged machines. The audited humanoid sales number is one unit.
WRC 2026 Exhibitor Map: 248 Robotics Companies Mapped
We classified 248 WRC 2026 exhibitors with the RobotToday taxonomy. Motion & Actuation leads at 75 companies, Humanoid at 72, and compute stays thin at 12. (Modified 2026-08-27)
WAIC Review 4/4: From Port AGVs to Hospital Night Shifts: What WAIC 2026 Reveals About Real Robot Deployments
From 530+ AGVs at a Singapore port to robots on Apple's line, WAIC 2026 speakers shared concrete data on where embodied AI robots are actually working today.
Johnson & Johnson Unveils Ottava Surgical Robot with Innovative Design and Features
Johnson & Johnson MedTech has introduced the Ottava surgical robot, which recently received FDA de novo authorization. This innovative system features four robotic arms integrated into the operating table, allowing for a space-saving design that occupies 30-50% less room than traditional boom-and-cart systems. The significance of the Ottava surgical robot lies in its ability to enhance surgical workflows and reduce setup time. By automating parts of the surgical process, the system aims to provide a more consistent experience for surgical teams, addressing common issues such as inadvertent suture cuts and dull scissors reported by surgeons. Looking ahead, the Ottava system's unique features, including a two-in-one needle driver and patented scissor design, are expected to improve surgical precision and efficiency. No further timeline was disclosed at the time of publication.
Healthcare Robotics Markets / Industries News Surgical / Interventional Systems Johnson & Johnson
ROBOTTODAY Weekly July 6 – 10, 2026
This week in robotics: AI² Robotics raises $735M for wheeled humanoids, Unitree G1 performs first live surgery, Dexmal launches DexOS platform, Agility Robotics announces SPAC, and Ondas acquires DZYNE for $875.8M. July 6–10, 2026.
ROBOTTODAY WEEKLY May 4 - 8, 2026
RobotToday Weekly covers the week's top robotics developments: Meta acquires humanoid robotics startup ARI, Genesis AI unveils GENE-26.5 foundation model, Hugging Face launches Reachy Mini robot app store, and 1X begins NEO humanoid production in California. Plus SoftBank's $100B robotics spinoff plans, $200M+ funding for humanoid robots, and 20 curated product launches across foundation models, robotaxi, surgical robotics, drone policy, and more. Curated for industry executives, investors, and robotics engineers.
Free Floating Ocean Robots Expose Weakening Carbon Sink
Free-floating ocean robots reveal weakening carbon sinks by tracking CO₂ and climate signals, offering new data on marine carbon cycling and environmental change.
